Director's Publications

• Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: a modelling study.Shoukat A, Wells CR, Shin T, Potter-Schwartz L, Galvani AP, Moghadas SM. Lancet Reg Health Am. 2025 Apr; 2025 Feb 19. PMID: 40046840.
• Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis.Sumsuzzman DM, Ye Y, Wang Z, Pandey A, Langley JM, Galvani AP, Moghadas SM. BMC Infect Dis. 2025 Feb 13; 2025 Feb 13. PMID: 39948450.
• Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults.Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP. Nat Med. 2025 Feb; 2025 Jan 9. PMID: 39789324.
• Integrating artificial intelligence with mechanistic epidemiological modeling: a scoping review of opportunities and challenges.Ye Y, Pandey A, Bawden C, Sumsuzzman DM, Rajput R, Shoukat A, Singer BH, Moghadas SM, Galvani AP. Nat Commun. 2025 Jan 10; 2025 Jan 10. PMID: 39794317.
• Quadrivalent Conjugate Vaccine and Invasive Meningococcal Disease in US Adolescents and Young Adults.Shin T, Wells CR, Shoukat A, Potter-Schwartz L, Langevin E, Langley JM, Galvani AP, Moghadas SM. JAMA Netw Open. 2024 Nov 4; 2024 Nov 4. PMID: 39504021.
• Estimating the lives that could be saved by expanded access to weight-loss drugs.Pandey A, Ye Y, Wells CR, Singer BH, Galvani AP. Proc Natl Acad Sci U S A. 2024 Oct 22; 2024 Oct 15. PMID: 39405358.
• Do COVID-19 Infectious Disease Models Incorporate the Social Determinants of Health? A Systematic Review.John-Baptiste AA, Moulin M, Li Z, Hamilton D, Crichlow G, Klein DE, Alemu FW, Ghattas L, McDonald K, Asaria M, Sharpe C, Pandya E, Moqueet N, Champredon D, Moghadas SM, Cooper LA, Pinto A, Stranges S, Haworth-Brockman MJ, Galvani A, Ali S. Public Health Rev. 2024; 2024 Oct 10. PMID: 39450316.
• Incorporating Social Determinants of Health in Infectious Disease Models: A Systematic Review of Guidelines.Ali S, Li Z, Moqueet N, Moghadas SM, Galvani AP, Cooper LA, Stranges S, Haworth-Brockman M, Pinto AD, Asaria M, Champredon D, Hamilton D, Moulin M, John-Baptiste AA. Med Decis Making. 2024 Oct; 2024 Sep 21. PMID: 39305116.
• Cost-effectiveness of Prefusion F Protein-based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Clin Infect Dis. 2024 May 15. PMID: 38035791.
• Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.Wells CR, Pandey A, Moghadas SM, Fitzpatrick MC, Singer BH, Galvani AP. Ann Intern Med. 2024 May; 2024 Mar 26. PMID: 38527289.
• Mortality and morbidity ramifications of proposed retractions in healthcare coverage for the United States.Pandey A, Fitzpatrick MC, Singer BH, Galvani AP. Proc Natl Acad Sci U S A. 2024 Apr 30; 2024 Apr 22. PMID: 38648491.
• A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients.Du Z, Wang L, Bai Y, Liu Y, Lau EHY, Galvani AP, Krug RM, Cowling BJ, Meyers LA. Elife. 2024 Apr 16; 2024 Apr 16. PMID: 38622989.
• An agent-based framework to study forced migration: A case study of Ukraine.Mehrab Z, Stundal L, Venkatramanan S, Swarup S, Lewis B, Mortveit HS, Barrett CL, Pandey A, Wells CR, Galvani AP, Singer BH, Leblang D, Colwell RR, Marathe MV. PNAS Nexus. 2024 Mar; 2024 Mar 19. PMID: 38505694.
• Impact and cost-effectiveness analyses of vaccination for prevention of respiratory syncytial virus disease among older adults in Ontario: A Canadian Immunization Research Network (CIRN) study.Shoukat A, Bawden CE, Röst G, LeBlanc JJ, Galvani AP, Langley JM, Moghadas SM. Vaccine. 2024 Mar 7; 2024 Feb 16. PMID: 38368226.
• Public Health Impact of Paxlovid as Treatment for COVID-19, United States.Bai Y, Du Z, Wang L, Lau EHY, Fung IC, Holme P, Cowling BJ, Galvani AP, Krug RM, Meyers LA. Emerg Infect Dis. 2024 Feb; 2024 Jan 5. PMID: 38181800.
• Seasonality of endemic COVID-19.Townsend JP, Hassler HB, Lamb AD, Sah P, Alvarez Nishio A, Nguyen C, Tew AD, Galvani AP, Dornburg A. mBio. 2023 Dec 19; 2023 Nov 8. PMID: 37937979.
• Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study.Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM. Lancet Reg Health Am. 2023 Dec; 2023 Nov 9. PMID: 38026446.
• The public health impact of Paxlovid COVID-19 treatment in the United States.Bai Y, Du Z, Wang L, Lau EHY, Fung IC, Holme P, Cowling BJ, Galvani AP, Krug RM, Meyers LA. medRxiv. 2023 Sep 7; 2023 Sep 7. PMID: 37732213.
• Cost-Effectiveness of Prefusion F Protein-Based Vaccines Against Respiratory Syncytial Virus Disease for Older Adults in the United States.Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. medRxiv. 2023 Aug 16; 2023 Aug 16. PMID: 37645896.
• Modelling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City.Pandey A, Fitzpatrick MC, Moghadas SM, Vilches TN, Ko C, Vasan A, Galvani AP. Lancet Reg Health Am. 2023 Aug; 2023 Jul 27. PMID: 37554154.
• Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.Laufer RS, Baral R, Buchwald AG, Campbell JD, Coulibaly F, Diallo F, Doumbia M, Driscoll AJ, Galvani AP, Keita AM, Neuzil KM, Sow S, Pecenka C, Ortiz JR, Fitzpatrick MC. PLOS Glob Public Health. 2023; 2023 May 5. PMID: 37145993.
• Estimated US Pediatric Hospitalizations and School Absenteeism Associated With Accelerated COVID-19 Bivalent Booster Vaccination.Fitzpatrick MC, Moghadas SM, Vilches TN, Shah A, Pandey A, Galvani AP. JAMA Netw Open. 2023 May 1; 2023 May 1. PMID: 37204795.
• Exacerbation of measles mortality by vaccine hesitancy worldwide.Pandey A, Galvani AP. Lancet Glob Health. 2023 Apr. PMID: 36925157.
• Role of immunity landscape in global risk assessment of re-emerging diseases.Pandey A, Galvani AP. Lancet Infect Dis. 2023 Apr; 2022 Nov 28. PMID: 36455592.
• Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.Carpiano RM, Callaghan T, DiResta R, Brewer NT, Clinton C, Galvani AP, Lakshmanan R, Parmet WE, Omer SB, Buttenheim AM, Benjamin RM, Caplan A, Elharake JA, Flowers LC, Maldonado YA, Mello MM, Opel DJ, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. Lancet. 2023 Mar 18; 2023 Mar 2. PMID: 36871571.
• Disease burden among Ukrainians forcibly displaced by the 2022 Russian invasion.Pandey A, Wells CR, Stadnytskyi V, Moghadas SM, Marathe MV, Sah P, Crystal W, Meyers LA, Singer BH, Nesterova O, Galvani AP. Proc Natl Acad Sci U S A. 2023 Feb 21; 2023 Feb 13. PMID: 36780515.
• The legacy of the COVID-19 pandemic for childhood vaccination in the USA.Opel DJ, Brewer NT, Buttenheim AM, Callaghan T, Carpiano RM, Clinton C, Elharake JA, Flowers LC, Galvani AP, Hotez PJ, Schwartz JL, Benjamin RM, Caplan A, DiResta R, Lakshmanan R, Maldonado YA, Mello MM, Parmet WE, Salmon DA, Sharfstein JM, Omer SB. Lancet. 2023 Jan 7; 2022 Oct 26. PMID: 36309017.
• Tackling the politicisation of COVID-19 data reporting through open access data sharing.Wells CR, Galvani AP. Lancet Infect Dis. 2022 Dec; 2022 Aug 31. PMID: 36057268.
• Economic evaluation of COVID-19 rapid antigen screening programs in the workplace.Vilches TN, Rafferty E, Wells CR, Galvani AP, Moghadas SM. BMC Med. 2022 Nov 23; 2022 Nov 23. PMID: 36424587.
• Return on Investment of the COVID-19 Vaccination Campaign in New York City.Sah P, Vilches TN, Moghadas SM, Pandey A, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP. JAMA Netw Open. 2022 Nov 1; 2022 Nov 1. PMID: 36409495.
• Estimating the impact of vaccination on reducing COVID-19 burden in the United States: December 2020 to March 2022.Sah P, Vilches TN, Pandey A, Schneider EC, Moghadas SM, Galvani AP. J Glob Health. 2022 Sep 3; 2022 Sep 3. PMID: 36056814.
• The global impact of disproportionate vaccination coverage on COVID-19 mortality.Wells CR, Galvani AP. Lancet Infect Dis. 2022 Sep; 2022 Jun 23. PMID: 35753320.
• Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.Mello MM, Opel DJ, Benjamin RM, Callaghan T, DiResta R, Elharake JA, Flowers LC, Galvani AP, Salmon DA, Schwartz JL, Brewer NT, Buttenheim AM, Carpiano RM, Clinton C, Hotez PJ, Lakshmanan R, Maldonado YA, Omer SB, Sharfstein JM, Caplan A. Lancet. 2022 Aug 13; 2022 Jul 8. PMID: 35817078.
• The durability of natural infection and vaccine-induced immunity against future infection by SARS-CoV-2.Townsend JP, Hassler HB, Sah P, Galvani AP, Dornburg A. Proc Natl Acad Sci U S A. 2022 Aug 2; 2022 Jul 15. PMID: 35858382.
• Exacerbation of COVID-19 mortality by the fragmented United States healthcare system: A retrospective observational study.Campbell T, Galvani AP, Friedman G, Fitzpatrick MC. Lancet Reg Health Am. 2022 Aug; 2022 May 12. PMID: 35582265.
• Testing for COVID-19 is Much More Effective When Performed Immediately Prior to Social Mixing.Wells CR, Gokcebel S, Pandey A, Galvani AP, Townsend JP. Int J Public Health. 2022; 2022 Jul 27. PMID: 35967267.
• Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19.Wells CR, Pandey A, Gokcebel S, Krieger G, Donoghue AM, Singer BH, Moghadas SM, Galvani AP, Townsend JP. PNAS Nexus. 2022 Jul; 2022 Jul 27. PMID: 35909795.
• Large numbers cause magnitude neglect: The case of government expenditures.Boyce-Jacino C, Peters E, Galvani AP, Chapman GB. Proc Natl Acad Sci U S A. 2022 Jul 12; 2022 Jul 7. PMID: 35867746.
• Comparative analyses of eighteen rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation.Wells CR, Pandey A, Moghadas SM, Singer BH, Krieger G, Heron RJL, Turner DE, Abshire JP, Phillips KM, Michael Donoghue A, Galvani AP, Townsend JP. Commun Med (Lond). 2022; 2022 Jul 9. PMID: 35822105.
• Universal healthcare as pandemic preparedness: The lives and costs that could have been saved during the COVID-19 pandemic.Galvani AP, Parpia AS, Pandey A, Sah P, Colón K, Friedman G, Campbell T, Kahn JG, Singer BH, Fitzpatrick MC. Proc Natl Acad Sci U S A. 2022 Jun 21; 2022 Jun 13. PMID: 35696578.
• Impact of the COVID-19 pandemic on cancer incidence and mortality.Wells CR, Galvani AP. Lancet Public Health. 2022 Jun. PMID: 35660207.
• The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: a modeling study.Zang X, Goedel WC, Bessey SE, Lurie MN, Galea S, Galvani AP, Friedman SR, Nosyk B, Marshall BDL. AIDS. 2022 May 1; 2022 Feb 24. PMID: 35212666.
• Incentives for COVID-19 vaccination.Brewer NT, Buttenheim AM, Clinton CV, Mello MM, Benjamin RM, Callaghan T, Caplan A, Carpiano RM, DiResta R, Elharake JA, Flowers LC, Galvani AP, Hotez PJ, Lakshmanan R, Maldonado YA, Omer SB, Salmon DA, Schwartz JL, Sharfstein JM, Opel DJ. Lancet Reg Health Am. 2022 Apr; 2022 Feb 24. PMID: 35229080.
• Cost-effective proactive testing strategies during COVID-19 mass vaccination: A modelling study.Du Z, Wang L, Bai Y, Wang X, Pandey A, Fitzpatrick MC, Chinazzi M, Pastore Y Piontti A, Hupert N, Lachmann M, Vespignani A, Galvani AP, Cowling BJ, Meyers LA. Lancet Reg Health Am. 2022 Apr; 2022 Jan 15. PMID: 35072146.
• Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study.Wells CR, Pandey A, Fitzpatrick MC, Crystal WS, Singer BH, Moghadas SM, Galvani AP, Townsend JP. Lancet Reg Health Eur. 2022 Mar; 2022 Jan 10. PMID: 35036981.
• COVID-19 hospitalizations and deaths averted under an accelerated vaccination program in northeastern and southern regions of the USA.Vilches TN, Sah P, Moghadas SM, Shoukat A, Fitzpatrick MC, Hotez PJ, Schneider EC, Galvani AP. Lancet Reg Health Am. 2022 Feb; 2021 Dec 29. PMID: 34977848.
• Estimating COVID-19 Infections, Hospitalizations, and Deaths Following the US Vaccination Campaigns During the Pandemic.Vilches TN, Moghadas SM, Sah P, Fitzpatrick MC, Shoukat A, Pandey A, Galvani AP. JAMA Netw Open. 2022 Jan 4; 2022 Jan 4. PMID: 35015067.
• Lives saved and hospitalizations averted by COVID-19 vaccination in New York City: a modeling study.Shoukat A, Vilches TN, Moghadas SM, Sah P, Schneider EC, Shaff J, Ternier A, Chokshi DA, Galvani AP. Lancet Reg Health Am. 2022 Jan; 2021 Oct 30. PMID: 34746912.
• Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study.Wells CR, Pandey A, Fitzpatrick MC, Crystal WS, Singer BH, Moghadas SM, Galvani AP, Townsend JP. medRxiv. 2021 Dec 17; 2021 Dec 17. PMID: 34729563.
• The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States.Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, Meyers LA, Neuzil KM, Langley JM, Fitzpatrick MC, Galvani AP. Clin Infect Dis. 2021 Dec 16. PMID: 33515252.
• Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, Carpiano RM, Clinton C, DiResta R, Elharake JA, Flowers LC, Galvani AP, Lakshmanan R, Maldonado YA, McFadden SM, Mello MM, Opel DJ, Reiss DR, Salmon DA, Schwartz JL, Sharfstein JM, Hotez PJ. Lancet. 2021 Dec 11; 2021 Nov 15. PMID: 34793741.
• The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.Townsend JP, Hassler HB, Wang Z, Miura S, Singh J, Kumar S, Ruddle NH, Galvani AP, Dornburg A. Lancet Microbe. 2021 Dec; 2021 Oct 1. PMID: 34632431.
• Implications of suboptimal COVID-19 vaccination coverage in Florida and Texas.Sah P, Moghadas SM, Vilches TN, Shoukat A, Singer BH, Hotez PJ, Schneider EC, Galvani AP. Lancet Infect Dis. 2021 Nov; 2021 Oct 7. PMID: 34627498.
• Population Immunity Against COVID-19 in the United States.Moghadas SM, Sah P, Shoukat A, Meyers LA, Galvani AP. Ann Intern Med. 2021 Nov; 2021 Sep 14. PMID: 34516275.
• Uncoupling vaccination from politics: a call to action.Sharfstein JM, Callaghan T, Carpiano RM, Sgaier SK, Brewer NT, Galvani AP, Lakshmanan R, McFadden SM, Reiss DR, Salmon DA, Hotez PJ. Lancet. 2021 Oct 2; 2021 Sep 16. PMID: 34537104.
• Routine saliva testing for the identification of silent coronavirus disease 2019 (COVID-19) in healthcare workers.Zhang K, Shoukat A, Crystal W, Langley JM, Galvani AP, Moghadas SM. Infect Control Hosp Epidemiol. 2021 Oct; 2021 Jan 11. PMID: 33427141.
• Importance of non-pharmaceutical interventions in the COVID-19 vaccination era: A case study of the Seychelles.Vilches TN, Sah P, Abdollahi E, Moghadas SM, Galvani AP. J Glob Health. 2021; 2021 Sep 18. PMID: 34671458.
• The Unrecognized Death Toll of COVID-19 in the United States.Moghadas SM, Galvani AP. Lancet Reg Health Am. 2021 Sep; 2021 Aug 10. PMID: 34396362.
• Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis.Sah P, Fitzpatrick MC, Zimmer CF, Abdollahi E, Juden-Kelly L, Moghadas SM, Singer BH, Galvani AP. Proc Natl Acad Sci U S A. 2021 Aug 24. PMID: 34376550.
• Quantifying the potential dominance of immune-evading SARS-CoV-2 variants in the United States.Sah P, Vilches TN, Shoukat A, Fitzpatrick MC, Pandey A, Singer BH, Moghadas SM, Galvani AP. medRxiv. 2021 Aug 18; 2021 Aug 18. PMID: 34013295.
• Cost-effectiveness of infant respiratory syncytial virus preventive interventions in Mali: A modeling study to inform policy and investment decisions.Laufer RS, Driscoll AJ, Baral R, Buchwald AG, Campbell JD, Coulibaly F, Diallo F, Doumbia M, Galvani AP, Haidara FC, Kotloff KL, Keita AM, Neuzil KM, Orenstein EW, Orenstein LAV, Pecenka C, Sow S, Tapia MD, Ortiz JR, Fitzpatrick MC. Vaccine. 2021 Aug 16; 2021 Jul 26. PMID: 34325934.
• Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy.Yamin D, Kahana D, Shahmoon E, Fitzpatrick MC, Galvani AP. BMC Public Health. 2021 Aug 12; 2021 Aug 12. PMID: 34384411.
• Can the USA return to pre-COVID-19 normal by July 4?Moghadas SM, Sah P, Vilches TN, Galvani AP. Lancet Infect Dis. 2021 Aug; 2021 Jun 2. PMID: 34089651.
• The interplay between COVID-19 restrictions and vaccination.Wells CR, Galvani AP. Lancet Infect Dis. 2021 Aug; 2021 Mar 31. PMID: 33811815.
• Role of the G20 in safe reopening of international travel.Pandey A, Galvani AP. Lancet Infect Dis. 2021 Jul. PMID: 34174233.
• Multifaceted strategies for the control of COVID-19 outbreaks in long-term care facilities in Ontario, Canada.Vilches TN, Nourbakhsh S, Zhang K, Juden-Kelly L, Cipriano LE, Langley JM, Sah P, Galvani AP, Moghadas SM. Prev Med. 2021 Jul; 2021 Apr 18. PMID: 33878351.
• Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout.Pandey A, Sah P, Moghadas SM, Mandal S, Banerjee S, Hotez PJ, Galvani AP. J Glob Health. 2021 Jun 26; 2021 Jun 26. PMID: 34221355.
• Mechanistic basis of post-treatment control of SIV after anti-α4β7 antibody therapy.Wells CR, Cao Y, Durham DP, Byrareddy SN, Ansari AA, Ruddle NH, Townsend JP, Galvani AP, Perelson AS. PLoS Comput Biol. 2021 Jun; 2021 Jun 9. PMID: 34106916.
• Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants.Sah P, Vilches TN, Moghadas SM, Fitzpatrick MC, Singer BH, Hotez PJ, Galvani AP. EClinicalMedicine. 2021 May; 2021 Apr 25. PMID: 33937735.
• Evaluation of COVID-19 vaccination strategies with a delayed second dose.Moghadas SM, Vilches TN, Zhang K, Nourbakhsh S, Sah P, Fitzpatrick MC, Galvani AP. PLoS Biol. 2021 Apr; 2021 Apr 21. PMID: 33882066.
• Timing is everything: the relationship between COVID outcomes and the date at which mask mandates are relaxed.Shoukat A, Galvani AP, Fitzpatrick MC. medRxiv. 2021 Apr 6; 2021 Apr 6. PMID: 33851171.
• Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination.Moghadas SM, Fitzpatrick MC, Shoukat A, Zhang K, Galvani AP. JAMA Netw Open. 2021 Apr 1; 2021 Apr 1. PMID: 33890990.
• Multifaceted strategies for the control of COVID-19 outbreaks in long-term care facilities in Ontario, Canada.Vilches TN, Nourbakhsh S, Zhang K, Juden-Kelly L, Cipriano LE, Langley JM, Sah P, Galvani AP, Moghadas SM. medRxiv. 2021 Mar 31; 2021 Mar 31. PMID: 33330884.
• Evaluation of COVID-19 vaccination strategies with a delayed second dose.Moghadas SM, Vilches TN, Zhang K, Nourbakhsh S, Sah P, Fitzpatrick MC, Galvani AP. medRxiv. 2021 Mar 26; 2021 Mar 26. PMID: 33532805.
• Racial disparities in COVID-19 mortality across Michigan, United States.Parpia AS, Martinez I, El-Sayed AM, Wells CR, Myers L, Duncan J, Collins J, Fitzpatrick MC, Galvani AP, Pandey A. EClinicalMedicine. 2021 Mar; 2021 Feb 26. PMID: 33718849.
• Comparative cost-effectiveness of SARS-CoV-2 testing strategies in the USA: a modelling study.Du Z, Pandey A, Bai Y, Fitzpatrick MC, Chinazzi M, Pastore Y Piontti A, Lachmann M, Vespignani A, Cowling BJ, Galvani AP, Meyers LA. Lancet Public Health. 2021 Mar; 2021 Feb 5. PMID: 33549196.
• Network structure and rapid HIV transmission among people who inject drugs: A simulation-based analysis.Singleton AL, Marshall BDL, Bessey S, Harrison MT, Galvani AP, Yedinak JL, Jacka BP, Goodreau SM, Goedel WC. Epidemics. 2021 Mar; 2020 Dec 14. PMID: 33341667.
• Optimizing age-specific vaccination.Fitzpatrick MC, Galvani AP. Science. 2021 Feb 26; 2021 Jan 21. PMID: 33479122.
• Simulated identification of silent COVID-19 infections among children and estimated future infection rates with vaccination.Moghadas SM, Fitzpatrick MC, Shoukat A, Zhang K, Galvani AP. medRxiv. 2021 Feb 26; 2021 Feb 26. PMID: 33442702.
• Universal health care needed to end HIV epidemic in the USA.Goedel WC, Marshall BDL, Galvani AP. Lancet HIV. 2021 Feb; 2020 Dec 22. PMID: 33357503.
• Cross-country evidence on the association between contact tracing and COVID-19 case fatality rates.Yalaman A, Basbug G, Elgin C, Galvani AP. Sci Rep. 2021 Jan 25; 2021 Jan 25. PMID: 33495491.
• Optimal COVID-19 quarantine and testing strategies.Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer B, McDonald RH, Fitzpatrick MC, Galvani AP. Nat Commun. 2021 Jan 7; 2021 Jan 7. PMID: 33414470.
• Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.Fitzpatrick MC, Pandey A, Wells CR, Sah P, Galvani AP. Lancet. 2021 Jan 2; 2020 Dec 14. PMID: 33333002.
• The impact of vaccination on COVID-19 outbreaks in the United States.Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, Meyers LA, Neuzil KM, Langley JM, Fitzpatrick MC, Galvani AP. medRxiv. 2021 Jan 2; 2021 Jan 2. PMID: 33269359.
• Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program in the First 22 Months of Implementation.Mera J, Williams MB, Essex W, McGrew KM, Boeckman L, Gahn D, Miller A, Durham D, Fox J, David C, Ritter T, Jones S, Bouse S, Galvani A, Ward JW, Drevets DA, Carabin H. JAMA Netw Open. 2020 Dec 1; 2020 Dec 1. PMID: 33337496.
• The impact of mask-wearing and shelter-in-place on COVID-19 outbreaks in the United States.Zhang K, Vilches TN, Tariq M, Galvani AP, Moghadas SM. Int J Infect Dis. 2020 Dec; 2020 Oct 9. PMID: 33039614.
• Effects of Cocooning on Coronavirus Disease Rates after Relaxing Social Distancing.Wang X, Du Z, Huang G, Pasco RF, Fox SJ, Galvani AP, Pignone M, Johnston SC, Meyers LA. Emerg Infect Dis. 2020 Dec; 2020 Sep 21. PMID: 32956613.
• COVID-19 on the African continent.Wells CR, Stearns JK, Lutumba P, Galvani AP. Lancet Infect Dis. 2020 Dec; 2020 May 6. PMID: 32618281.
• Routine saliva testing for the identification of silent COVID-19 infections in healthcare workers.Zhang K, Shoukat A, Crystal W, Langley JM, Galvani AP, Moghadas SM. medRxiv. 2020 Nov 30; 2020 Nov 30. PMID: 33269362.
• Optimal COVID-19 quarantine and testing strategies.Wells CR, Townsend JP, Pandey A, Moghadas SM, Krieger G, Singer B, McDonald RH, Fitzpatrick MC, Galvani AP. medRxiv. 2020 Nov 30; 2020 Nov 30. PMID: 33173923.
• Estimations du taux de létalité de la COVID-19 au Canada et aux États-Unis sur une période donnée.Abdollahi E, Champredon D, Langley JM, Galvani AP, Moghadas SM. CMAJ. 2020 Nov 16. PMID: 33199459.
• The effect of Medicare for All on rural hospitals - Authors' reply.Fitzpatrick MC, Galvani AP. Lancet. 2020 Oct 31. PMID: 33129384.
• Projection de la demande de lits de soins intensifs durant l’épidémie de COVID-19 au Canada.Shoukat A, Wells CR, Langley JM, Singer BH, Galvani AP, Moghadas SM. CMAJ. 2020 Oct 26. PMID: 33106307.
• Impact of Social Distancing Measures on Coronavirus Disease Healthcare Demand, Central Texas, USA.Wang X, Pasco RF, Du Z, Petty M, Fox SJ, Galvani AP, Pignone M, Johnston SC, Meyers LA. Emerg Infect Dis. 2020 Oct; 2020 Jul 21. PMID: 32692648.
• Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA.Wells CR, Fitzpatrick MC, Sah P, Shoukat A, Pandey A, El-Sayed AM, Singer BH, Moghadas SM, Galvani AP. Lancet Infect Dis. 2020 Oct; 2020 Apr 21. PMID: 32325039.
• Robert May, 1936-2020: A man for all disciplines.Galvani A, Hastings A, Levin SA, Singer BH. Proc Natl Acad Sci U S A. 2020 Sep 22; 2020 Sep 10. PMID: 32913048.
• The burden of childhood pneumonia in India and prospects for control.Pandey A, Galvani AP. Lancet Child Adolesc Health. 2020 Sep. PMID: 32827486.
• Effects of Proactive Social Distancing on COVID-19 Outbreaks in 58 Cities, China.Du Z, Xu X, Wang L, Fox SJ, Cowling BJ, Galvani AP, Meyers LA. Emerg Infect Dis. 2020 Sep; 2020 Jun 9. PMID: 32516108.
• Dogs and pigs are transport hosts of Necator americanus: Molecular evidence for a zoonotic mechanism of human hookworm transmission in Ghana.Boyko RH, Marie Harrison L, Humphries D, Galvani AP, Townsend JP, Otchere J, Wilson MD, Cappello M. Zoonoses Public Health. 2020 Aug; 2020 Jun 11. PMID: 32529782.
• The implications of silent transmission for the control of COVID-19 outbreaks.Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP. Proc Natl Acad Sci U S A. 2020 Jul 28; 2020 Jul 6. PMID: 32632012.